Medical Compression Talks on Asset Sale Postponed on FDA Issue
Medical Compression Systems (DBN) Ltd. said talks to sell its DVT assets were postponed until the U.S. Food and Drug Administration responds to answers provided by the company to issues relating to the manufacturing process. Medical Compression expects the FDA response within three months, according to a statement filed today with the Tel Aviv Stock Exchange.
To contact the reporter on this story: Susan Lerner in Jerusalem at email@example.com
To contact the editor responsible for this story: Alisa Odenheimer at firstname.lastname@example.org